Usana Health Sciences
USNA
138 hedge funds and large institutions have $243M invested in Usana Health Sciences in 2026 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 32 reducing their positions, and 18 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 32
35% more capital invested
Capital invested by funds: $180M → $243M (+$63.4M)
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
5.99% more ownership
Funds ownership: 55.68% → 61.67% (+6%)
1% less funds holding
Funds holding: 139 → 138 (-1)
33% less call options, than puts
Call options by funds: $284K | Put options by funds: $421K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.84M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$4.23M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$4.08M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.1M |
| 5 |
Pzena Investment Management
New York
|
+$1.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.24M |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$1.23M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$1.14M |
| 4 |
Renaissance Technologies
New York
|
-$1.11M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.11M |
USNA Hedge Fund Activity: Q2 2026 in Review
138 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2026, worth a combined $243M — up 35% from $180M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new USNA positions and 18 closed out — a net gain of 5 holders — while 61 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock, adding an estimated $6.84M. The largest seller was Millennium Management, cutting an estimated $1.24M.
- 138 institutional investors held Usana Health Sciences (USNA) as of Q2 2026, down from 139 in Q1 2026.
- Funds reported $243M of Usana Health Sciences stock for Q2 2026, up 35% quarter-over-quarter.
- 23 funds opened new Usana Health Sciences positions in Q2 2026 and 18 closed out, a net change of +5 holders.
- The largest Usana Health Sciences buyer in Q2 2026 was BlackRock, an estimated $6.84M added.
- The largest Usana Health Sciences seller in Q2 2026 was Millennium Management, an estimated $1.24M sold.
Based on aggregated 13F filings for Q2 2026.